Clinical Research On Treating The Chronic Pelvic Inflammatory Disease With The Tongren Zhongzi Decoction

Objective: Mixture analysis of gynecological inflammation inflammatory jointKangfute heat treatment of chronic pelvic inflammatory suppository clinical efficacy andmechanism of a preliminary study of its role. Methods： Randomly selected in January2012to December2012to our hospital and diagnosed as damp-heat of120patients withchronic pelvic inflammatory disease for the study were randomly divided into observationgroup and control group, n=60cases, observation group oral anti-inflammatory agentsgynecological inflammatory joint rehabilitation topical treatment of anal suppository racecontrol group, anti-inflammatory suppository rehabilitation treatment alone, compared twogroups of patients before and after treatment were observed before and after treatmentsyndromes, local signs of improvement, blood science, uterine artery blood flow and pelvicB-changing circumstances.Results: Observation group after treatment cure rate, markedlyeffective rate and total effective rate was significantly higher, which was observed inpatients after treatment, the total effective93.43%significantly higher than78.33%, thedifference was statistically significant (P <0.05). After three cycles of treatment,60patients in the observation group,13patients achieved clinical symptoms cure standard,recovery rate21.67%, the total efficiency of95.00%,11patients achieved partial signs ofrecovery standard medicine, the cure rate is18.33%the total effective rate was91.67%,while the control group of60patients with clinical symptoms after treatment cure rate was8.33%, the total effective rate was76.67%in the control group local signs after treatmentcure rate was3.33%, the total effective rate was53.67%in the observation group cure rateand total effective rate was significantly higher, the difference was statistically significant(P <0.05). After treatment, clinical symptoms and signs was significantly lower than beforetreatment, after treatment were statistically significant (P <0.05). After treatment, clinical symptoms and signs significantly lower than the control group, the difference wasstatistically significant (P <0.05). Two groups of patients before treatment compared to avariety of clinical symptoms and signs were no significant differences (P>0.05); signs andsymptoms after treatment in both improved in both groups compared with before treatmentdifference was statistically significant (P <0.05), the observation group after treatment,abdominal bulge pain/lumbar pain, tenderness attachment area/palpable mass, uterineactivity is poor/adhesions fixed symptoms improved significantly compared with thecontrol group, the difference was statistically significant (P <0.05). After treatment, sixmonths no recurrence, while the control group, the recurrence rate was11.67%,significantly higher than the observation group, the difference was statistically significant(P <0.05). After12months of treatment relapse rate was6.67%in observation group wassignificantly lower than the control group,26.67%, the difference was statisticallysignificant (P <0.05). Both groups during treatment and found no adverse reactions inpatients with significant. Conclusion: Gynecological anti-inflammatory agents combinedheat Kangfute inflammatory suppository treatment of chronic pelvic inflammatory diseasecan significantly improve the patient’s clinical signs and symptoms, probably by regulatingthe body’s immune function in order to promote the repair of damaged cells and tissues,and promote the absorption of inflammatory cells, the treatment damp-effective drug forchronic cervicitis, worthy of clinical application.